Phase 3 Trial Data Highlights Efficacy of OnabotulinutoxinA in Platysma Prominence
Sachin Shridharani, MD, discusses the results of a recent Allergan Aesthetics study exploring the efficacy of onabotulinumtoxinA in treating platysma prominence.